Review



slc1a5 protein levels  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Proteintech slc1a5 protein levels
    Slc1a5 Protein Levels, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc1a5+protein+levels/ASCT2+Antibody/pm41436769-170-0-11
    Average 95 stars, based on 77 article reviews
    slc1a5 protein levels - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    Western Blot:

    Article Title: NEDD4 suppresses ferroptosis in lung ischemia-reperfusion injury by ubiquitinating and degrading SLC1A5.
    Article Snippet: .. SLC1A5 protein levels were detected by Western blot using anti-SLC1A5 antibody (Proteintech, #20350-1-AP, 1:8,000), while β-actin served as loading control. ..

    Control:

    Article Title: NEDD4 suppresses ferroptosis in lung ischemia-reperfusion injury by ubiquitinating and degrading SLC1A5.
    Article Snippet: .. SLC1A5 protein levels were detected by Western blot using anti-SLC1A5 antibody (Proteintech, #20350-1-AP, 1:8,000), while β-actin served as loading control. ..



    Similar Products

    slc1a5 protein levels  (Proteintech)
    95
    Proteintech slc1a5 protein levels
    Slc1a5 Protein Levels, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc1a5+protein+levels/ASCT2+Antibody/pm41436769-170-0-11
    Average 95 stars, based on 1 article reviews
    slc1a5 protein levels - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    slc1a5 protein expression levels  (Human Protein Atlas)
    90
    Human Protein Atlas slc1a5 protein expression levels
    Basic information on <t>SLC1A5</t> across cancers. ( A ) Expression levels of SLC1A5 in normal and cancerous tissues. ( B ) Immunohistochemistry and HE staining of SLC1A5 in normal brain and glioma tissues. ( C ) Alteration frequency of SLC1A5 across cancers based on the cBioPortal database. ( D ) Immunofluorescence images of SLC1A5 protein expression in the nucleus, endoplasmic reticulum (ER), and microtubules in A-431 and U-251 cells. ( E ) The protein‒protein interaction (PPI) network shows the proteins interacting with SLC1A5.
    Slc1a5 Protein Expression Levels, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc1a5+protein+levels/slc1a5+staining/pmc10457057-214-10-0
    Average 90 stars, based on 1 article reviews
    slc1a5 protein expression levels - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Basic information on SLC1A5 across cancers. ( A ) Expression levels of SLC1A5 in normal and cancerous tissues. ( B ) Immunohistochemistry and HE staining of SLC1A5 in normal brain and glioma tissues. ( C ) Alteration frequency of SLC1A5 across cancers based on the cBioPortal database. ( D ) Immunofluorescence images of SLC1A5 protein expression in the nucleus, endoplasmic reticulum (ER), and microtubules in A-431 and U-251 cells. ( E ) The protein‒protein interaction (PPI) network shows the proteins interacting with SLC1A5.

    Journal: Aging (Albany NY)

    Article Title: SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis

    doi: 10.18632/aging.204911

    Figure Lengend Snippet: Basic information on SLC1A5 across cancers. ( A ) Expression levels of SLC1A5 in normal and cancerous tissues. ( B ) Immunohistochemistry and HE staining of SLC1A5 in normal brain and glioma tissues. ( C ) Alteration frequency of SLC1A5 across cancers based on the cBioPortal database. ( D ) Immunofluorescence images of SLC1A5 protein expression in the nucleus, endoplasmic reticulum (ER), and microtubules in A-431 and U-251 cells. ( E ) The protein‒protein interaction (PPI) network shows the proteins interacting with SLC1A5.

    Article Snippet: Human Protein Atlas (THPA, https://www.proteinatlas.org/ ) was used to detect SLC1A5 protein expression levels in pathological tissues and to confirm protein distribution at the subcellular level.

    Techniques: Expressing, Immunohistochemistry, Staining, Immunofluorescence

    Correlation of SLC1A5 with single-cell classes in the pancancer microenvironment. ( A ) Heatmap showing the expression levels of SLC1A5 in 33 single cell types. ( B ) Scatterplot showing the GSE120575 dataset and the distribution of 10 different types of single cells. ( C ) Scatter plot showing the GSE131928 dataset and the distribution of 10 different types of single cells.

    Journal: Aging (Albany NY)

    Article Title: SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis

    doi: 10.18632/aging.204911

    Figure Lengend Snippet: Correlation of SLC1A5 with single-cell classes in the pancancer microenvironment. ( A ) Heatmap showing the expression levels of SLC1A5 in 33 single cell types. ( B ) Scatterplot showing the GSE120575 dataset and the distribution of 10 different types of single cells. ( C ) Scatter plot showing the GSE131928 dataset and the distribution of 10 different types of single cells.

    Article Snippet: Human Protein Atlas (THPA, https://www.proteinatlas.org/ ) was used to detect SLC1A5 protein expression levels in pathological tissues and to confirm protein distribution at the subcellular level.

    Techniques: Expressing

    Correlation analysis between SLC1A5 and the prognosis of different cancer patients. ( A ) The summary of correlation analysis between SLC1A5 and patients’ overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI) and progression-free interval (PFI) was analyzed by univariate Cox regression and Kaplan‒Meier. Red indicates that SLC1A5 is a risk factor for this type of cancer, and green indicates a protective factor. Only p values < 0.05 are shown. ( B ) Forest plot of the relationship between SLC1A5 and the prognosis of cancer patients analyzed by univariate Cox regression. Red markers indicate that SLC1A5 is a risk factor for this cancer type. ( C – F ) Kaplan‒Meier overall survival curves of SLC1A5 in LIHC ( C ), LGG ( D ), KIRC ( E ) and MESO ( F ).

    Journal: Aging (Albany NY)

    Article Title: SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis

    doi: 10.18632/aging.204911

    Figure Lengend Snippet: Correlation analysis between SLC1A5 and the prognosis of different cancer patients. ( A ) The summary of correlation analysis between SLC1A5 and patients’ overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI) and progression-free interval (PFI) was analyzed by univariate Cox regression and Kaplan‒Meier. Red indicates that SLC1A5 is a risk factor for this type of cancer, and green indicates a protective factor. Only p values < 0.05 are shown. ( B ) Forest plot of the relationship between SLC1A5 and the prognosis of cancer patients analyzed by univariate Cox regression. Red markers indicate that SLC1A5 is a risk factor for this cancer type. ( C – F ) Kaplan‒Meier overall survival curves of SLC1A5 in LIHC ( C ), LGG ( D ), KIRC ( E ) and MESO ( F ).

    Article Snippet: Human Protein Atlas (THPA, https://www.proteinatlas.org/ ) was used to detect SLC1A5 protein expression levels in pathological tissues and to confirm protein distribution at the subcellular level.

    Techniques:

    Gene set enrichment analysis (GSEA) of the SLC1A5 gene set across cancers. The size of the circle indicates the FDR value of the enriched element in each cancer, and the color indicates the normalized enrichment score (NES).

    Journal: Aging (Albany NY)

    Article Title: SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis

    doi: 10.18632/aging.204911

    Figure Lengend Snippet: Gene set enrichment analysis (GSEA) of the SLC1A5 gene set across cancers. The size of the circle indicates the FDR value of the enriched element in each cancer, and the color indicates the normalized enrichment score (NES).

    Article Snippet: Human Protein Atlas (THPA, https://www.proteinatlas.org/ ) was used to detect SLC1A5 protein expression levels in pathological tissues and to confirm protein distribution at the subcellular level.

    Techniques:

    Correlation of SLC1A5 expression with immune infiltration levels of B cells, CD4+ T cells, CD8+ T cells, dendritic cells, Endo, Eos, CAF, progenitor, mast cells, HSC, macrophages, monocytes, Tfh, γδT, NKT, regulatory T cells (Tregs), neutrophils, NK cells, and MDSCs in cancers. Red and blue indicate positive and negative correlations, respectively.

    Journal: Aging (Albany NY)

    Article Title: SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis

    doi: 10.18632/aging.204911

    Figure Lengend Snippet: Correlation of SLC1A5 expression with immune infiltration levels of B cells, CD4+ T cells, CD8+ T cells, dendritic cells, Endo, Eos, CAF, progenitor, mast cells, HSC, macrophages, monocytes, Tfh, γδT, NKT, regulatory T cells (Tregs), neutrophils, NK cells, and MDSCs in cancers. Red and blue indicate positive and negative correlations, respectively.

    Article Snippet: Human Protein Atlas (THPA, https://www.proteinatlas.org/ ) was used to detect SLC1A5 protein expression levels in pathological tissues and to confirm protein distribution at the subcellular level.

    Techniques: Expressing

    Relationship between SLC1A5 and immunotherapy-independent efficacy predictive biomarkers. ( A ) The Spearman correlation heatmap shows that the expression level of SLC1A5 is correlated with 46 immunostimulators and 24 immunoinhibitors. Red indicates a positive correlation and blue indicates a negative correlation. ( B ) The relationship between SLC1A5 expression level and tumor mutation burden (TMB) in cancer patients. ( C ) The relationship between the SLC1A5 expression level and microsatellite instability (MSI) in cancer patients. The labeled asterisk indicates the statistical p value ( * p < 0.05, ** p < 0.01, *** p < 0.001).

    Journal: Aging (Albany NY)

    Article Title: SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis

    doi: 10.18632/aging.204911

    Figure Lengend Snippet: Relationship between SLC1A5 and immunotherapy-independent efficacy predictive biomarkers. ( A ) The Spearman correlation heatmap shows that the expression level of SLC1A5 is correlated with 46 immunostimulators and 24 immunoinhibitors. Red indicates a positive correlation and blue indicates a negative correlation. ( B ) The relationship between SLC1A5 expression level and tumor mutation burden (TMB) in cancer patients. ( C ) The relationship between the SLC1A5 expression level and microsatellite instability (MSI) in cancer patients. The labeled asterisk indicates the statistical p value ( * p < 0.05, ** p < 0.01, *** p < 0.001).

    Article Snippet: Human Protein Atlas (THPA, https://www.proteinatlas.org/ ) was used to detect SLC1A5 protein expression levels in pathological tissues and to confirm protein distribution at the subcellular level.

    Techniques: Expressing, Mutagenesis, Labeling

    In vitro evidence that SLC1A5 is involved in the proliferation and migration of glioma cells. ( A ) RNA and ( B ) protein expression levels of SLC1A5 in astrocytes and glioma cell lines. ( C – E ) RT‒qPCR and Western blotting verified the knockdown efficiency of SLC1A5 in U251 and U118 cell lines, respectively. ( F ) Colony formation experiments were performed to analyze the effect of SLC1A5 downregulation on the colony formation ability of U251 and U118 cell lines, and ( G , H ) statistical analysis was performed. ( I , J ) Cell proliferation ability was evaluated using the CCK-8 assay, and proliferation curves were plotted. ( K ) Cell migration ability was determined by transwell migration assay. The labeled asterisk indicates the statistical p value ( * p < 0.05, ** p < 0.01, *** p < 0.001).

    Journal: Aging (Albany NY)

    Article Title: SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis

    doi: 10.18632/aging.204911

    Figure Lengend Snippet: In vitro evidence that SLC1A5 is involved in the proliferation and migration of glioma cells. ( A ) RNA and ( B ) protein expression levels of SLC1A5 in astrocytes and glioma cell lines. ( C – E ) RT‒qPCR and Western blotting verified the knockdown efficiency of SLC1A5 in U251 and U118 cell lines, respectively. ( F ) Colony formation experiments were performed to analyze the effect of SLC1A5 downregulation on the colony formation ability of U251 and U118 cell lines, and ( G , H ) statistical analysis was performed. ( I , J ) Cell proliferation ability was evaluated using the CCK-8 assay, and proliferation curves were plotted. ( K ) Cell migration ability was determined by transwell migration assay. The labeled asterisk indicates the statistical p value ( * p < 0.05, ** p < 0.01, *** p < 0.001).

    Article Snippet: Human Protein Atlas (THPA, https://www.proteinatlas.org/ ) was used to detect SLC1A5 protein expression levels in pathological tissues and to confirm protein distribution at the subcellular level.

    Techniques: In Vitro, Migration, Expressing, Western Blot, Knockdown, CCK-8 Assay, Transwell Migration Assay, Labeling

    SLC1A5 inhibits ferroptosis in glioma cells. ( A , B ) The level of GSH was measured in U251 and U118 cells after SLC1A5 knockdown. ( C , D ) The level of MDA was measured in U251 and U118 cells after SLC1A5 knockdown. ( E , F ) The RNA expression levels of the ferroptosis gene GPX4 were detected in U251 and U118 cell lines after SLC1A5 knockdown. ( G , H ) The RNA expression levels of the ferroptosis gene ACSL4 in U251 and U118 cell lines were detected after SLC1A5 knockdown. ( I ) Western blotting was used to detect the protein expression levels of GPX4 and ACSL4 after SLC1A5 knockdown. The labeled asterisk indicates the statistical p value ( * p < 0.05, ** p < 0.01, *** p < 0.001).

    Journal: Aging (Albany NY)

    Article Title: SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis

    doi: 10.18632/aging.204911

    Figure Lengend Snippet: SLC1A5 inhibits ferroptosis in glioma cells. ( A , B ) The level of GSH was measured in U251 and U118 cells after SLC1A5 knockdown. ( C , D ) The level of MDA was measured in U251 and U118 cells after SLC1A5 knockdown. ( E , F ) The RNA expression levels of the ferroptosis gene GPX4 were detected in U251 and U118 cell lines after SLC1A5 knockdown. ( G , H ) The RNA expression levels of the ferroptosis gene ACSL4 in U251 and U118 cell lines were detected after SLC1A5 knockdown. ( I ) Western blotting was used to detect the protein expression levels of GPX4 and ACSL4 after SLC1A5 knockdown. The labeled asterisk indicates the statistical p value ( * p < 0.05, ** p < 0.01, *** p < 0.001).

    Article Snippet: Human Protein Atlas (THPA, https://www.proteinatlas.org/ ) was used to detect SLC1A5 protein expression levels in pathological tissues and to confirm protein distribution at the subcellular level.

    Techniques: Knockdown, RNA Expression, Western Blot, Expressing, Labeling